Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ETR/0QF stock hub

ETR/0QF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/0QFis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
18.3B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/0QF
In the news

Latest news · ETR/0QF

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 15.7P75 20.2
Trailing P/En/a
P25 16.4P50 20.9P75 30.4
ROE-36.6
P25 -6.7P50 8.5P75 17.2
ROIC-66.2
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/0QF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
171
Groups with data
11
Currency
USD
Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
DE
Employees
4,700
Employees Change
-1,100%
Employees Change Percent
-18.97
Enterprise value
EUR 13.1B
Exchange
Deutsche Börse Xetra
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
US60770K1079
Last refreshed
2026-05-10
Market cap
EUR 18.3B
Price
EUR 46.92
Price currency
EUR
Rev Per Employee
410,583.51x
Sector
Healthcare
Sic
2836
Symbol
etr/0QF
Website
https://www.modernatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-15.12%
EV Earnings
-4.73x
EV/FCF
-9.42x
EV/Sales
6.92x
FCF yield
-7.59%
P/B ratio
2.85x
P/S ratio
9.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
-113.89%
EBITDA Margin
-103.33%
Gross margin
-69.89%
Gross Profit
EUR -1.3B
Net Income
EUR -2.8B
Pretax Margin
-141.03%
Profit Margin
-143.55%
Profit Per Employee
EUR -589,395
ROA
-13.09
Roa5y
6.72
ROCE
-27.87
ROE
-36.56
Roe5y
22.02
ROIC
-66.19
Roic5y
177.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
123.07%
Cagr3y
-27.42%
Cagr5y
-19.04%
Revenue Growth
-29.97x
Revenue Growth Q
260.19x
Revenue Growth3 Y
-47.13x
Revenue Growth5 Y
-4.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
EUR 0.18
Assets
EUR 10B
Cash
EUR 4.5B
Current Assets
EUR 4.9B
Current Liabilities
EUR 2B
Debt
EUR 1.1B
Debt Equity
EUR 0.18
Debt FCF
EUR -0.81
Equity
EUR 6.4B
Interest Coverage
-97.46
Liabilities
EUR 3.5B
Long Term Assets
EUR 5.1B
Long Term Liabilities
EUR 1.5B
Net Cash
EUR 5.3B
Net Cash By Market Cap
EUR 29.15
Net Cash Growth
-19.48%
Net Debt Equity
EUR -0.83
Tangible Book Value
EUR 6.3B
Tangible Book Value Per Share
EUR 15.82
WACC
9.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.41
Inventory Turnover
27.59
Net Working Capital
EUR -1.5B
Quick ratio
2.23
Working Capital
EUR 2.9B
Working Capital Turnover
EUR 0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
122.95%
200-day SMA
30.84
3Y total return
-61.77%
50-day SMA
44.33
50-day SMA vs 200-day SMA
50over200
5Y total return
-65.21%
All Time High
426.5
All Time High Change
-89%
All Time High Date
2021-08-10
All Time Low
19.37
All Time Low Change
142.18%
All Time Low Date
2025-11-21
ATR
2.62
Beta
1.06
Ch YTD
76.92
High
48
High52
50.57
High52 Date
2026-03-05
High52ch
-7.22%
Low
41.59
Low52
19.37
Low52 Date
2025-11-21
Low52ch
142.18%
Ma50ch
5.84%
Price vs 200-day SMA
52.16%
RSI
60.59
RSI Monthly
47.52
RSI Weekly
66.35
Sharpe ratio
1.36x
Sortino ratio
2.32
Total Return
-1.62%
Tr YTD
76.92
Tr1m
12.53%
Tr1w
15.58%
Tr3m
37.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -2.2B
Operating margin
-113.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
370,094,602%
Net Borrowing
491,817,960
Shares Insiders
6.64%
Shares Institutions
80.34%
Shares Qo Q
0.77%
Shares Yo Y
1.62%
Short Ratio
7.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
EUR -1.8B
Average Volume
12,232.95x
Bv Per Share
16.18
CAPEX
EUR -118.8M
Ch1m
12.53
Ch1w
15.58
Ch1y
123
Ch3m
37.25
Ch3y
-61.77
Ch5y
-65.21
Ch6m
130.7
Change
13.55%
Change From Open
12.65
Close
41.32
Days Gap
0.8
Depreciation Amortization
199,271,070
Dollar Volume
2,088,690.7
Earnings Date
2026-05-01
EBIT
EUR -2.2B
EBITDA
EUR -2B
EPS
EUR -7.08
F Score
2
FCF
EUR -1.4B
FCF EV Yield
-10.62x
Financing CF
525,583,800
Fiscal Year End
December
Founded
2,010
Goodwill
44,094,024
Income Tax
EUR 48.6M
Investing CF
988,722,000
Is Primary Listing
0
Last Earnings Date
2026-05-01
Last Report Date
2026-03-31
Ma150
33.49
Ma150ch
40.08%
Ma20
43.53
Ma20ch
7.78%
Net CF
245,445,900
Open
41.65
Position In Range
83.15
Ppne
2,367,509,904
Price Date
2026-05-08
Ptbv Ratio
2.92
Relative Volume
3.64x
Revenue
1,929,742,500x
SBC By Revenue
21.21x
Share Based Comp
409,365,600
Tax By Revenue
2.52x
Tr6m
130.74%
Volume
44,516
Z Score
2.36
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ETR/0QF pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/0QF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+123.0%
S&P 500 1Y: n/a
3Y total return
-61.8%
S&P 500 3Y: n/a
5Y total return
-65.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ETR/0QF?

Insider, institutional, and short-interest positioning.

Institutional ownership
+80.3%
Share of float held by funds and institutions
Insider ownership
+6.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
7.4 days to cover
Y/Y dilution
+1.6%
Negative means the company is buying back shares.
Technical

ETR/0QF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.6
Neutral momentum band
Price vs 200-day MA
+52.2%
50/200-day relationship not available
Beta (5Y)
1.06
Moves roughly with the market
Sharpe ratio
1.36
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/0QF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/0QF stock rating?

etr/0QF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/0QF analysis?

The full report lives at /stocks/etr/0QF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/0QF?

The latest report frames etr/0QF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/0QF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

etr/0QF stock profile: metrics, valuation and analysis | StockMarketAgent.AI